A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.


Updates from The Motley Fool

Latest updates on Cytokinetics from Fool.com.


Stock Performance

CYTK vs. S&P 500 | 2 Year Performance
View Interactive CYTK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cytokinetics.
Current Price: $8.76
Prev Close: $8.83
Open: $8.84
Bid: $8.60
Ask: $9.58
Day's Range: $8.69 - $9.00
52wk Range: $6.00 - $13.18
Volume: 279,838
Avg Vol 395,701
Market Cap: $340.30M
P/E (ttm): -8.18
EPS (ttm): -$1.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cytokinetics.
CAPS Rating 2 out of 5
 
163 Outperform
20 Underperform
CAPS All Stars
 
36 Outperform
6 Underperform

How do you think Cytokinetics will perform against the market?



You pick for Cytokinetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert I. Blum, CEO

64% Approve

Based on 5 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cytokinetics.

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers